PLTP and hepatocellular carcinoma: In this study, PLTP was found to be one of the core DEPs in patients with HCC and non-HCC in an HIV/HBV co-infected population, implying that PLTP can be used as a candidate protein to aid in the diagnosis of HCC in this population, and is expected to provide certain clues for the investigation of the mechanism of targeted therapy for HCC.